MALARIAIMPFSTOFF

European patent · EP3540057 · In force

Register entry

Publication number
EP3540057
Application number
EP17869200
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 10, 2017
Published
Sep 18, 2019
Granted
Sep 2, 2026
Protection ends at the latest
Nov 9, 2037
Next annual fee due
Nov 30, 2026
IPC classes
C12N 15/09 (2006.01)
A61K 39/015 (2006.01)
A61K 39/13 (2006.01)
C07K 14/445 (2006.01)
C07K 16/20 (2006.01)
C07K 17/02 (2006.01)
C12N 1/19 (2006.01)
C12N 1/21 (2006.01)
C12N 5/10 (2006.01)
A61K 39/05 (2006.01)
A61K 39/08 (2006.01)
A61K 39/10 (2006.01)
A61P 33/06 (2006.01)
A61P 37/04 (2006.01)
A61P 43/00 (2006.01)
Priority
JP 2016220512 11.11.2016
JP 2017161442 24.08.2017
PCT application
PCT/JP2017/040532 10.11.2017
PCT publication
WO2018/088507 17.05.2018
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 2, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 02.09.2026

Parties

Holder

Sumitomo Pharma Co., Ltd.

6-8, Doshomachi 2-chome Chuo-ku, Osaka-shi,, Osaka 541-0045, JP

National University Corporation Ehime University

10-13, Dogo-himata Matsuyama-shi, Ehime 790-8577, JP

Inventor

FUKUSHIMA, Akihisa

Osaka-shi Osaka 554-0022, JP

TSUBOI, Takafumi

Matsuyama-shi Ehime 790-8577, JP

TAKASHIMA, Eizo

Matsuyama-shi Ehime 790-8577, JP

NAGAOKA, Hikaru

Matsuyama-shi Ehime 790-8577, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.